NICE guidance increases treatment options for patients with severe ankylosing spondylitis



The National Institute for Health and Care Excellence (NICE) has published guidance recommending infliximab for use within its marketing authorisation as an option for treating severe active…



Source link

sticket2

Would you like to get the test?

This entry was posted in Uncategorized. Bookmark the permalink.